-
Only 1 in 4 Adolescent Treatment Facilities Offer Buprenorphine for Opioid Use Disorder
Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Only 1 in 8 offer buprenorphine for ongoing treatment. These findings highlight a significant gap in...
-
Still Reaching: The Syndemics that Complicate and Characterize How Drugs and HIV Intersect in People’s Lives
Nearly 42 years ago, the Centers for Disease Control and Prevention (CDC) reported a rare pneumonia in five gay men, marking the recognized start of the HIV/AIDS epidemic. While we often hear about those men’s sexuality, we hear less often about their substamce use. As the 1981 report notes,...
-
Prenatal Cannabis Exposure Associated With Mental Disorders in Children That Persist Into Early Adolescence
Prenatal cannabis exposure following the middle of the first trimester – generally after five to six weeks of fetal development – is associated with attention, social, and behavioral problems that persist as the affected children progress into early adolescence (11 and 12 years of age),...
-
Increased Use of Telehealth for OUD Services During COVID-19 Pandemic Associated With Reduced Risk of Overdose
The expansion of telehealth services for opioid use disorder (OUD) during the COVID-19 pandemic was associated with individuals staying in treatment longer and reducing their risk of medically treated overdose, according to a new study. Published today in JAMA Psychiatry, this study was a...
-
Buprenorphine Initiation in the ER Found Safe and Effective for Individuals With Opioid Use Disorder Who Use Fentanyl
Results from a multi-site clinical trial supported by the National Institutes of Health showed that less than 1% of people with opioid use disorder whose drug use includes fentanyl experienced withdrawal when starting buprenorphine in the ER. The findings, which appeared today in JAMA Network Open,...
-
Creating Sustainable Homes for Prevention Services
The addiction and overdose crisis in the U.S. continues unabated, with more than 46 million people having a substance use disorder (SUD) in 2021 and more than 100,000 people dying from drug overdose annually. The crisis is increasingly hitting adolescents. Fentanyl, the main driver of overdose...
-
Overdose Deaths Involving Buprenorphine Did Not Proportionally Increase With New Flexibilities in Prescribing
The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in place during the COVID-19 pandemic, according to a new study. These data provide evidence that may help to...
-
School Prevalence of Stimulant Therapy for ADHD Associated With Higher Rates of Prescription Stimulant Misuse Among Teens
Researchers have identified a strong association between the prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of prescription stimulant misuse (taken in a way other than as directed by a clinician) by students in middle and high schools. The...
-
Time to Start Talking About Pre-Addiction
By the time someone reaches out for addiction care, they may have already suffered numerous painful losses in their lives. Addiction can steal a person’s happiness, job, friends and family, and can erode their freedom. Far too often, the expectation is that someone must hit “rock...
-
Young Men at Highest Risk of Schizophrenia Linked with Cannabis Use Disorder
Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of Denmark and the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The...
